April 10, 2025 - 03:06
Morgan Stanley has decided to withdraw its financing support for KKR & Co.’s acquisition of Karo Healthcare, a Swedish consumer-health company. This decision comes amid increasing market volatility and uncertainty, prompting the financial institution to reassess its involvement in the deal.
Sources close to the matter indicate that the current economic climate has influenced Morgan Stanley's choice, as fluctuating market conditions pose risks to large-scale transactions. KKR & Co., a prominent global investment firm, was in the process of finalizing the acquisition, which is now left in a precarious position without the backing of one of its key financial partners.
The withdrawal of financing not only complicates the acquisition process for Karo Healthcare but also raises questions about the future of similar deals in the consumer health sector. Market analysts will be closely monitoring the situation as it unfolds, particularly how it may impact investor confidence in high-value transactions in the current economic landscape.
